DUBLIN--(BUSINESS WIRE)--The "U.S. Age-Related Macular Degeneration Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.
This report provides comprehensive insights into Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.
The research is classified into following sections - Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Age-Related Macular Degeneration prevalence trends by countries; Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.
Key Topics Covered
1. Age-Related Macular Degeneration: Disease Overview
1.1. Age-Related Macular Degeneration Symptoms
1.2. Age-Related Macular Degeneration Etiology
1.3. Age-Related Macular Degeneration Diagnosis
1.4. Age-Related Macular Degeneration Treatment Options
2. Age-Related Macular Degeneration Pipeline Insights
2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials
3. Age-Related Macular Degeneration Epidemiology Analysis
4. US Age-Related Macular Degeneration Market Insights
4.1. Marketed Products for Age-Related Macular Degeneration in US
4.2. US Age-Related Macular Degeneration Market Size & Forecast
4.3. US Age-Related Macular Degeneration Product Sales Forecast
List of Tables
Table 1: Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2018
Table 2: Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2018
Table 3: Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2018
Table 4: Age-Related Macular Degeneration Prevalence , US, 2017 - 2023
Table 5: Marketed Products for Age-Related Macular Degeneration in US, 2017
Table 6: US Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 7: US Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
List of Figures
Figure 1: Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2018
Figure 2: Age-Related Macular Degeneration Prevalence, US, 2017 - 2023
Figure 3: US Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 4: US Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 5: US Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 6: US Age-Related Macular Degeneration Market - Future Market Share (%), 2023
For more information about this report visit https://www.researchandmarkets.com/research/rmscbg/u_s_agerelated?w=4
